SWEDEN

Menu

Home

Home

A.Menarini Diagnostics Announces Agreement with Skyla Corporation in the area of Point of Care Testing

Hsinchu, Taiwan and Florence, Italy, July 24th, 2020

ralesci Congresses with "Zero Impact®" on the environmentive drug for chronic hyperuricaemia in gout.D VitaPCR^® POC instrument.

On August 20th the German Minister of Health, Jens Spahn visited the Red Cross Hospital of Mölln-Ratzeburg.

A.MENARINI DIAGNOSTICS and BIOACTIVA DIAGNOSTICA GMBH SIGN AN EXCLUSIVE AGREEMENT FOR LIOFERON^® TB/LTBI, A TEST TO DIAGNOSE LATENT TUBERCULOSIS INFECTION.

September 3rd, 2020 – Firenze, Italy and Bad Homburg, Germany

A.MENARINI DIAGNOSTICS and BIOACTIVA DIAGNOSTICA GMBH SIGN AN EXCLUSIVE AGREEMENT FOR LIOFERON^® TB/LTBI, A TEST TO DIAGNOSE LATENT TUBERCULOSIS INFECTION.

September 3rd, 2020 – Firenze, Italy and Bad Homburg, Germany

Menarini Diagnostics acquires EOS Preanalytics and Point Of Care company assets

FLORENCE, January 15th, 2021 - Menarini Diagnostics, a company of the Menarini Group

Our values

4 values, which have given life to Menarini and shaped its history

A. Menarini Diagnostics S.r.l., Italien Filial (Sverige) | Single member company | Registered office: Via Sette Santi 3 - 50131 Florence (Italy) | Registration no. in registrar of companies: 05478500480 | Registrar of companies' office: Florence | Registered capital: € 100,000 fully paid-in | Capital reported in last financial statement: € 100,000

Company subject to the direction and coordination of A. Menarini Industrie Farmaceutiche Riunite Srl | A. Menarini Diagnostics S.r.l., Italien Filial (Sverige) | Medeon Science Park, P A Hanssons väg 41, hus D 214 32 Malmö | Telefon: +46 40 32 12 70 | Fax: +46 40 32 12 71 | Contact us | VD: Johan Vikner | Organisationsnr: 516408-1217 | Innehar F-skattebevis: VAT-nr SE516408121701. | Bankgiro: 5658-9211 | IBAN: SE0412000000013710111617"

© 2024 A. Menarini Diagnostics s.r.l - All rights reserved